Elevated methemoglobin levels in patients treated with high-dose hydroxocobalamin
Laboratory Medicine · 2024
DOI: 10.1093/labmed/lmad037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, 2024. Verfasst von Martinus Dyrud und 2 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Cardiac & Vascular Institute, Memorial Healthcare System, Hollywood, FL, US. Hauptthemen laut MEDLINE: Methemoglobin, Hydroxocobalamin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Objective
The aim of this study was to assess the impact of hydroxocobalamin (OHCbl) infusion on arterial blood gas and oximetry values in patients with vasoplegic syndrome.
Methods
Blood samples collected from 95 patients receiving OHCbl infusion were assayed using the ABL90 FLEX Plus blood gas analyzer for the concentration of methemoglobin (MetHb), total hemoglobin (tHb), carboxyhemoglobin (COHb), arterial oxygen saturation (SaO2), arterial oxygen partial pressure (PaO2), and arterial carbon dioxide partial pressure (PaCO2). Interference of OHCbl on these variables was evaluated using the measured difference between the preinfusion and postinfusion samples.
Results
Blood MetHb (%) measured after the infusion of OHCbl (5g) were significantly higher than the baseline levels, with a median of 4.8 (IQR, 3.0−6.5) versus 1.0 (IQR, 1.0−1.2) (P < .001). Blood COHb (%) increased from a median of 1.3 (IQR, 1.0−1.8) to 1.7 (IQR, 1.3−2.2) (P < .001) following the OHCbl infusion. No differences were seen in median levels of tHb, PaO2, PaCO2, and SaO2 between pre- and post-OHCbl treatment.
Conclusion
The presence of OHCbl in blood clearly interfered with the oximetry measurements of the hemoglobin component fractions by falsely increasing the levels of MetHb and COHb. Blood levels of MetHb and COHb cannot be reliably determined by the co-oximetry when OHCbl is known or suspected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Memorial Cardiac & Vascular Institute, Memorial Healthcare System, Hollywood, FL, US.
ORCID-Profile: Martinus Dyrud, Jianli Niu
Zitieren
APA
Dyrud, M., Niu, J., & Kohler, L. (2024). Elevated methemoglobin levels in patients treated with high-dose hydroxocobalamin. Laboratory Medicine. https://doi.org/10.1093/labmed/lmad037
Vancouver
Dyrud M, Niu J, Kohler L. Elevated methemoglobin levels in patients treated with high-dose hydroxocobalamin. Laboratory Medicine. 2024. doi:10.1093/labmed/lmad037
BibTeX
@article{Dyrud2024,
author = {Dyrud, Martinus and Niu, Jianli and Kohler, Lisa},
title = {Elevated methemoglobin levels in patients treated with high-dose hydroxocobalamin},
journal = {Laboratory Medicine},
year = {2024},
doi = {10.1093/labmed/lmad037}
}
EUVIMED